Excelera, a technology-enabled care delivery platform, ageed to go public via a SPAC merger with Future Health, a blank check company, in a $459m deal. After transaction expenses, the proposed business combination is expected to deliver at least $105m, and up to $282m of net proceeds, including the contribution of up to $201m of cash held in Future Health’s trust account and a $100m fully subscribed private placement of common stock of the combined company, priced at $11 per share. "Our mission with Future Health was to identify and bring to the public markets a disruptive company that leverages modern technology and data-science to improve outcomes, reduce waste, and better personalize care. It is difficult to imagine a company better aligned with this mission than Excelera. What they’ve established is a truly novel and impactful approach to value-based care, and we are excited to partner with the talented Excelera team to create exceptional shareholder value while improving lives with smarter and more proactive healthcare," Bradley Bostic, Future Health Co-Founder and CEO.